Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicia Cosman

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 13, 2020
Modeling-Based Bone Formation in the Human Femoral Neck in Subjects Treated With DenosumabDavid W Dempster, Arkadi Chines, Mathias P Bostrom, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 25, 2018
FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to DenosumabFelicia Cosman, Daria B Crittenden, Serge Ferrari, et al.
The Journal of Clinical Endocrinology and Metabolism|August 29, 2014
A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosisJohan Halse, Susan Greenspan, Felicia Cosman, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2009
Effect of transdermal teriparatide administration on bone mineral density in postmenopausal womenFelicia Cosman, Nancy E Lane, Michael A Bolognese, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 24, 2020
T-Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH TrialFelicia Cosman, E Michael Lewiecki, Peter R Ebeling, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 14, 2011
Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosisMaria-Grazia Ascenzi, Vivian P Liao, Brittany M Lee, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 12, 2018
Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture OutcomeFelicia Cosman, Daria B Crittenden, Serge Ferrari, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 3, 2009
Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosisPierre D Delmas, Francoise Munoz, Dennis M Black, et al.
American Journal of Obstetrics and Gynecology|May 20, 2005
The effects of hormone replacement on the biomechanical properties of the uterosacral and round ligaments in the monkey modelMichael D Vardy, Thomas R Gardner, Felicia Cosman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 5, 2024
Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 studyLiana Tripto-Shkolnik, Auryan Szalat, Gloria Tsvetov, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 13, 2020
Modeling-Based Bone Formation in the Human Femoral Neck in Subjects Treated With DenosumabDavid W Dempster, Arkadi Chines, Mathias P Bostrom, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 25, 2018
FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to DenosumabFelicia Cosman, Daria B Crittenden, Serge Ferrari, et al.
The Journal of Clinical Endocrinology and Metabolism|August 29, 2014
A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosisJohan Halse, Susan Greenspan, Felicia Cosman, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2009
Effect of transdermal teriparatide administration on bone mineral density in postmenopausal womenFelicia Cosman, Nancy E Lane, Michael A Bolognese, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 24, 2020
T-Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH TrialFelicia Cosman, E Michael Lewiecki, Peter R Ebeling, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 14, 2011
Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosisMaria-Grazia Ascenzi, Vivian P Liao, Brittany M Lee, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 12, 2018
Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture OutcomeFelicia Cosman, Daria B Crittenden, Serge Ferrari, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 3, 2009
Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosisPierre D Delmas, Francoise Munoz, Dennis M Black, et al.
American Journal of Obstetrics and Gynecology|May 20, 2005
The effects of hormone replacement on the biomechanical properties of the uterosacral and round ligaments in the monkey modelMichael D Vardy, Thomas R Gardner, Felicia Cosman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 5, 2024
Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 studyLiana Tripto-Shkolnik, Auryan Szalat, Gloria Tsvetov, et al.
Pageof 12